Zyomyx Appoints New Member to Board of Directors | GenomeWeb

NEW YORK, April 3 – Protein chip developer Zyomyx said Tuesday that Raju Kucherlapati has joined its board of directors.

Kucherlapati was a founder of Cell Genesys and Millennium Pharmaceuticals and currently serves as a director for Abgenix, Millennium, and Valentis.

Kucherlapati completed his postdoctoral work at Yale University and was awarded a PhD in genetics from the University of Illinois, Urbana.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.